Robinhood Ventures

Since 1991, Bob has worked at SEI (http://www.seic.com), a diversified financial services company located in Oaks, PA and the leading global provider of outsourced asset management, investment processing and investment operations solutions. His responsibilities there focused mainly on SEI’s asset management businesses and distribution of those services to high net worth individuals and financial advisors in the U.S. and Europe.

Prior to joining SEI, Bob spent five years with the Procter & Gamble Company as a Brand Manager in the Paper Division.

Bob received a B.S. from the U.S. Naval Academy in Annapolis, MD. After graduation, he served six years as an officer in the U.S. Marine Corps in the U.S. and Asia.

David is an entrepreneur, business executive, angel investor and consultant. In 1996, David co-founded and was President and CEO of MarketSpan, Inc., whose CaseStream® service aggregated and enhanced court docket information and created new research tools and marketing opportunities for legal professionals. David sold MarketSpan in 2000 to CourtLink. CourtLink was acquired by Lexis-Nexis in late 2001.

Since MarketSpan, David has been an active angel investor (and a more present husband and father than he was previously). David has invested in more than 15 start-ups--and even has made money on some. David is Vice-Chairman of the Mid-Atlantic Angel Group Fund I, L.P., a past-President of Robin Hood Ventures, and a member of L.O.R.E. (Loosely Organized Retired Executives). David has served on the Board of Directors or Board of Advisors of several start-ups and early stage companies, including: Satori Group, Inc.; Inference Data; Vaticor, Inc.; Patient Confidence Corporation of America ; and MicroMRI.
As President of Bookspan Consulting, LLC, David actively consults in the fields of information services and law, for clients such as LexisNexis and Ikon Office Solutions.

Prior to MarketSpan, David practiced law for 15 years and was a litigation partner at Wolf, Block Schorr and Solis-Cohen, in Philadelphia, PA. David earned an A.B. degree from Vassar College and a J.D. from Georgetown University Law Center where David was an Editor of the Law Review.

Tim is President and founder of Sterling Investment Advisors, Ltd., and has 25 years of experience in the financial services industry. Sterling Investment Advisors, Ltd., provides investment advising to corporations, high-net-worth individuals, endowments and qualified plans. Their client list includes many prominent corporations and entrepreneurs. Sterling has been named to the “Philadelphia 100” as one of the fastest growing companies in the Philadelphia region. Sterling acquired Preswick Capital Management in January of 2007.

Tim’s responsibilities include investment analysis, executive compensation plans, portfolio risk management and quantitative portfolio reporting. In addition to having a Series 7 license, Tim is also a General Securities Principal (series 24) and a Registered Options Principal (Series 4, held by only 2.4% of brokers in the US). He has completed advanced training in technical analysis and is also a Chartered Financial Consultant.

Tim has co-founded two financial service companies that presently oversee $700 million of investment assets.

Tim was a founding member of Robin Hood Ventures, and has served as President of the Board of Directors of RHV.

In 2005, Tim was elected to the Board of Directors of Alliance Bank, NASDAQ symbol ALLB. He serves on their Forward Planning Committee and their Compensation Committee.

Tim and his wife Kathy, have four children and live in Berwyn, PA. He is a member of Waynesborough Country Club and the Patrons Foundation of Philadelphia.

Michael Levinson co-founded PTS Learning Systems in 1986. PTS was focused on corporate computer training and electronic performance support software. By 1999, the company had grown into a highly profitable international organization with approximately 250 employees in 4 countries and revenues of $30 million. PTS was sold in 1999 to Global Knowledge Network, a $450 million Welsh Carson-backed information technology training organization.

Since selling PTS, Mike has gotten involved in a number of activities. In early 2001, Mike co-founded Founders LaunchPad, an organization of entrepreneurs looking to brainstorm and potentially co-found new businesses. Mike also became an active investor in two young technology companies: Profiler Technologies, LLC and TechWise Group, Inc. Profiler Technologies offers software/ASP solutions to the training and staffing markets; helping them add functionality to their web sites and allowing them to more quickly and effectively place graduating students and staffing personnel. TechWise Group is an information technology firm which delivers training and consulting services to medium-sized businesses in the Philadelphia to New York corridor.

Mike graduated from the Wharton School of the University of Pennsylvania with an Economics/Accounting degree, obtained his CPA certificate in Pennsylvania, and graduated from Villanova Law School with a JD.

Maria Maccecchini received her PhD in biochemistry from Rockefeller University and spent two years at Caltech as a postdoc in molecular biology. She took her first job at Mallickrodt as research scientist and her second job as general manager of Bachem Bioscience, a US subsidiary of a Swiss company.

In the early 1990s she started her own biotech company—Symphony Pharmaceuticals. After acquiring the Scottish and Japanese company Cruachem, Symphony later changed its name to Annovis. The company develops, manufactures, and markets a variety of nucleic acid-based products and services for businesses in the life sciences sector. In 2001, Annovis was acquired by Transgenomic Inc. of San Jose, CA.

Dr. Maccecchini serves on several boards of biotechnology companies, organizations that promote entrepreneurship, international trade as well as women and charitable organizations. Currently she is a member and director Robin Hood Ventures and also invests through the Mid-Atlantic Angel Group. In April 2006, Maria received the PIF, Saul Ewing Angel of the Year Award. This award is presented to the angel investor who exemplifies angel investing not only by investing dollars in companies but who also spends time mentoring early stage companies or provided particularly significant contributions to companies in which they invest in addition to cash.

She has been having fun with "extreme travel," including climbing Mt. Everest and dog-sledding in Alaska.

George Marks is a co-founder of Robin Hood Ventures and current Board member / Membership chairman. His experience relates to the management of almost $5,000,000 in investment to Robin Hood-related companies since the organizations founding in 1999.

He is a founding partner in the architectural firm of Kramer/Marks Architects specializing in larger commercial and residential projects with an additional degree in structural engineering. He also develops and manages a portfolio of Commercial Real Estate investments in the Tri-state PA, NJ & DE region. His expertise relates to service businesses and those involved in customer satisfaction.

Mark has over 25 years' experience in information technology consulting and outsourcing, as well as change management projects for Accenture. Currently, Mark is the founder and managing director of Ingenium Group. He provides executive coaching and leadership development services to senior executives.

Mark has a BSI, Industrial and Operations Engineering, from the University of Michigan.

John Moran had 19 years in a variety of capacities with Synthes (USA), the leading manufacturer of orthopedic implants used in fracture repair. His positions included Director of Finance, VP of Finance and Administration, VP of Product Development, and President of the Spinal Implant Division.

Since leaving Synthes in 1997, he has been a private investor in a number of companies, mostly in the medical device field. He is on the board of Paradigm Spine, LLC, Ranier Technology, Anika Therapeutics (a publicly-held company located in Woburn, MA), and Power Medical Interventions, Inc.

Claudia Piccirilli founded the business and technology consulting firm of Piccirilli Partners, LLC in 2003. Piccirilli Partners is dedicated to helping companies improve business performance through strong business analysis, performance improvement, design and implementation of practical technology solutions.

Ms. Piccirilli is intimately familiar with custom development of software and implementation of a wide variety of enterprise solutions, such as SAP and Oracle. She has experience with software design and implementation in many industry sectors, including, but not limited to: Manufacturing, Financial Services, HealthCare, Consumer Products, and Life Sciences.

Ms. Piccirilli has served as a Senior Vice President in Information Technology at CIGNA, BancONE and as a Vice President in Business & Technology at JPMorgan. She has developed project life cycle methodologies, and designed and completed a cadre of significant business projects that involved complex application development, delivering profitable returns for a variety of companies. She is a seasoned veteran of management decision-making and investment, and has guided Fortune 500 companies in the establishment of portfolio management offices which manage business investment and return, ensuring value for investment. She has managed international and multi-location initiatives with significantly sizable teams and returns.

Claudia graduated with her B.S. degree from the University of Pittsburgh, and obtained her MBA from Villanova University. She has considerable expertise in Business Analysis, Operations Research/Improvement, Application Development, Portfolio Management and Technology process improvement. She has served as a senior advisor to a number of Fortune 500 senior executives on both business and technology issues.

Jeff Strider

Jeff's background includes 14 years in the audit department of Price Waterhouse serving the firm's middle market and entrepreneurial clients. He spent 10 years in the firm's Richmond, Va. office and 4 years in its Philadelphia, Pa. office.

In 1992, he joined a small litigation consulting practice and in 1993 helped transition that practice to a stand alone firm. In addition to providing accounting and audit related consulting services in litigated matters and corporate investigations, Jeff served as the firm's Managing Director from 1997 until its sale to FTI Consulting, Inc., a public company, in October 2003. Since April 2006, he has focused on various personal and family investments.

Jeff received a B.S. in Commerce from the University of Virginia.

Howard P. Treatman is the founding principal of Harvest Equities, Inc., a national real estate investment firm based in Philadelphia. Since its formation in 2000, Harvest Equities has acquired over 3,750 apartment units and over 900,000 square feet of office space in Connecticut, the District of Columbia, Florida, Maryland, Pennsylvania, Texas and Wisconsin.

Harvest focuses on the long-term hold of core real estate, and positions itself to capitalize on changing capital and real estate market conditions. Harvest adds value through its sophisticated and innovative financing strategies, which have resulted in extraordinary after-tax returns.

Howard has a unique blend of professional expertise in real estate, finance, capital markets, law and tax, derived from over 19 years of experience in commercial real estate. Howard is a licensed attorney (inactive) in the state of Pennsylvania, having practiced for several years with Wolf, Block, Schorr & Solis-Cohen. Howard received his Juris Doctor degree in 1986 from Cornell Law School and his Bachelor of Arts degree in 1983 from the University of Pennsylvania, Cum Laude.

David Twersky has over 25 years of corporate experience as the founder and former CEO of Dixon-Shane Drug Company, a Philadelphia-based wholesale distributor, manufacturer, and packager of branded and generic pharmaceuticals, servicing government agencies, retail pharmacies, medical clinics, and managed care organizations. Under David’s entrepreneurial leadership, the business grew from sales of $200,000 in 1977 to $40 million in sales in 2002, when he negotiated the sale of his company. For the next fifteen months, David managed the post-acquisition transition overseeing both daily operations and implementing new organizational initiatives.

David was a co-founder and the first President of the Premier Distributor Group, a group purchasing organization of independent pharmaceutical wholesalers throughout the United States. Its primary purpose was to leverage the members’ combined purchasing power, in excess of $300 million annually, to negotiate more favorable pricing and terms.

Prior to entering the business world, David, who holds graduate degrees in Clinical Psychology and Clinical Social Work, was a practicing family therapist and a college-level Social Sciences instructor.

Currently, David is an active investor in and advisor to innovative early-stage companies and the President of Robin Hood Ventures, a Philadelphia angel investor group. He also provides business mentoring and pharmaceutical consulting services. David has served on several for-profit, as well as non-profit, advisory and governing Boards including Ethidium Health Systems, Take Care Health Systems, Synova Healthcare, Ben Franklin Technology Partners, Robin Hood Ventures, Mid-Atlantic Angel Fund, Planned Parenthood Federation of America, and the Huntingdon Valley, Pa Library.

Rob Weber has held a variety of executive positions for emerging technology companies. He is currently President of Intellifit Corporation (www.intellifit.com), a provider of guaranteed fit technology for on-line apparel shopping. Prior to Intellifit, Rob served as a co-founder of Antiphony. Prior to Antiphony he served as President of knoa, an e-learning software company, where he successfully redefined the corporate product strategy and repositioned the company to capitalize on new market opportunities. Additionally, he served as President of Elastomeric Technologies, a leading electronic connector manufacturer.

Rob is a founder of Robin Hood Ventures, an angel investment fund focused on emerging growth companies. Rob has served as a Lecturer at The Wharton School where he taught business planning and entrepreneurial management. Rob earned Bachelor of Science in Economics (B.S.E.) and Bachelor of Applied Science (B.A.S.) degrees from The Wharton School and School of Engineering at The University of Pennsylvania.

In July 2007 (at the tender age of 30), Steven sold the Mitos group of companies that he had started building 6 years earlier to Parker Hannifin (NYSE: PH)—an S&P 500 company. Steven founded Mitos Technologies, Inc. (the first Mitos company) in January 2001. At Mitos Technologies Steven engineered and patented the Mitos FREE FLOW^® valve—the premier valve for biopharmaceutical manufacturing. Steven marketed this valve as part of a product line for use in biopharmaceutical pilot plants and manufacturing facilities.

In the summer of 2001, Steven co-founded I-4, Inc., which developed and patented several material solution products that addressed the specific needs of the biopharmaceutical industry. In June of 2004, Mitos Technologies, Inc. acquired full ownership of I-4.

In August of 2002, Steven worked with a group of investors to purchase the manufacturing division of ST-Silicones, one of Mitos Technologies, Inc.’s key suppliers, now named Mitos Molding, Inc. In January 2007 Mitos Technologies acquired full ownership of this business.

In the fall of 2005, Steven led the creation of Mitos BioSystems division which developed and manufactured disposable biologic systems. These systems integrated the patented FREE FLOW valve along with molded components and two patented mixings systems.

Steven grew up in the Philadelphia region where he attended Unionville High School. After receiving his degree in mechanical engineering from Pennsylvania State University in 1999, Steven started his career at W.L. Gore & Associates. Since selling Mitos, Steven has been an active angel investor.